Compare IRMD & CIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IRMD | CIM |
|---|---|---|
| Founded | 1992 | 2007 |
| Country | United States | United States |
| Employees | N/A | 423 |
| Industry | Medical/Dental Instruments | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.1B |
| IPO Year | 2014 | N/A |
| Metric | IRMD | CIM |
|---|---|---|
| Price | $100.97 | $13.12 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 2 |
| Target Price | ★ $116.00 | $15.25 |
| AVG Volume (30 Days) | 131.0K | ★ 797.2K |
| Earning Date | 05-01-2026 | 05-07-2026 |
| Dividend Yield | 0.95% | ★ 10.92% |
| EPS Growth | ★ 16.67 | N/A |
| EPS | ★ 0.45 | N/A |
| Revenue | ★ $83,814,000.00 | N/A |
| Revenue This Year | $12.38 | $1.62 |
| Revenue Next Year | $11.31 | $2.48 |
| P/E Ratio | $217.87 | ★ N/A |
| Revenue Growth | ★ 14.43 | N/A |
| 52 Week Low | $55.11 | $11.67 |
| 52 Week High | $107.90 | $14.88 |
| Indicator | IRMD | CIM |
|---|---|---|
| Relative Strength Index (RSI) | 68.51 | 42.36 |
| Support Level | $96.43 | $13.05 |
| Resistance Level | $105.87 | $13.19 |
| Average True Range (ATR) | 3.67 | 0.28 |
| MACD | 0.53 | -0.01 |
| Stochastic Oscillator | 96.95 | 6.02 |
iRadimed Corp develops, manufactures, markets, and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system, which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates the majority revenue from United States.
Chimera Investment Corporation is an internally managed REIT whose principal business objective is to provide attractive risk-adjusted returns and distributable income through investment performance linked to mortgage credit fundamentals. Through its mortgage lending, investment management, and advisory services platforms, the Company operates as a fully integrated mortgage business that originates, manages, and invests in a diversified range of mortgage assets. The Company invests, directly or indirectly, generally on a levered basis across a spectrum of mortgage assets, including residential mortgage loans, Non-Agency RMBS, Agency RMBS, Agency CMBS, MSRs, business purpose and investor loans, including RTLs, and other real estate-related assets.